Qiliqiangxin Affects L Type Ca(2+) Current in the Normal and Hypertrophied Rat Heart

Qiliqiangxin capsule is newly developed Chinese patent drug and proved to be effective and safe for the treatment of patients with chronic heart failure. We compared the effects of different dose Qiliqiangxin on L type Ca(2+) current (I (Ca-L)) between normal and hypertrophied myocytes. A total of 4...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wei, Yidong, Liu, Xiaoyu, Hou, Lei, Che, Wenliang, The, Erlinda, Jhummon, Muktanand Vikash
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3320132/
https://ncbi.nlm.nih.gov/pubmed/22536279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/131830
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados